Turkey: Recent Developments In Pharmaceuticals

The sensitive political nature of healthcare and pharmaceuticals has made this sector one of the most heavily regulated in Turkey. Parallel with scientific developments in pharmaceuticals, the relevant legislation has been amended and updated to embrace the new realities. The central piece of legislation on licensing pharmaceuticals is the Regulation on Licensing Medicinal Products for Human Use1 ("Regulation"). On 22 April 2009, several amendments were made to the Regulation, and in this article we will review them and examine implementation of the Regulation.

There is a new concept introduced by the Regulation under the "Definitions" section, and that is "co-marketing," allowing identical products manufactured in the same release batch – with the same qualitative and quantitative composition and the same pharmaceutical form – to be marketed under different trade names. Another amendment made under "Definitions" relates to the generic product. Although the definition of a generic product was not changed, Article 4 of the Regulation has clarified that as long as the different salts, esters, ethers, isomers, enantiomers, mixes, complexes or derivatives of isomers of an active material are not significantly different with regard to properties of safety and/or efficiency, they will be treated as the same active material.

According to the "License Applications" under Article 5 of the Regulation, the license holder should inform the Ministry of Health when the product is introduced into the market, and the Ministry of Health will inform the license holder within five (5) business days at the latest that this information has been recorded. The same Article further stipulates that if the efficiency and safety of radiopharmaceuticals prepared as a magistery are proven in the world or Turkey and routinely used, and relevant literature evidencing this fact is submitted to the Ministry of Health, no license is required, provided that the use of those radiopharmaceuticals is regulated by the relevant health institution.

Article 8 of the Regulation stipulates the information and documentation required for the license application, and features certain amendments.

  1. In applying for a license, certain analyses, tests and controls may be discarded in accordance with the approval of the Ministry of Health, provided that they do not affect the safety and quality of the product.
  2. For the import or licensed manufacture of a product that has been licensed abroad, the applicant should undertake that the Summary of Product Characteristics ("SPC") is updated. In addition to the SPC, operating manual and sample packages, a translation of these documents should be submitted.
  3. If the product to be manufactured under license, imported or manufactured in Turkey is to be co-marketed, in addition to current requirements the written approval of the natural persons or legal entities that will co-market the product, as well as information on Module-1, will be required.
  4. Within the framework of pharmacovigilance practices, address, telephone, fax number, job description and resume of the person responsible for product safety and the description of the scientific service, as well as the address, telephone and fax number of the scientific service, will be required.

In compliance with Article 15 of the Regulation, the Ministry of Health will finalize the license application within 210 days. However, if the product is innovative and will reduce public health expenses, the application will be finalized within 180 days at the latest. If the product is to be co-marketed and the license application of the reference product has been made, but the production is not licensed yet, the applications for both products will be reviewed concurrently. If the reference product is licensed in Turkey, the Ministry of Health will only review the information on Module-1 and finalize the application within 90 days.

Articles 22 and 23 of the Regulation provide that in case the license of a product is suspended or cancelled, manufacture and importation of that product will cease. The previous version of the Regulation only provided for the cessation of manufacture.

The amendments under Article 25 of the Regulation regarding change of license holder are noteworthy. Upon transfer of license, the SPC to be submitted should be "updated." In the former version of Article 25 of the Regulation, it was stipulated that the company of origin may "unilaterally" change the real or legal person authorized to license and sell the product in Turkey. However, the word "unilaterally" has been removed from that Article in the new version, meaning that the manufacturer can no longer unilaterally change the existing authorized natural person/legal entity. This amendment will prevent foreign manufacturers from unilaterally changing their licensed local distributors.

Additional documents are required for changing the existing authorized natural person/legal entity. These are either the letter from the existing license holder stating that the original license has been returned, or the court order stating that the existing license holder is no longer authorized. With regard to license transfers before a notary public, there are documents to be submitted to the Ministry of Health: (i) an undertaking letter prepared by the company that will be new license holder, stating that no modification has been made to the product during the transfer application, and (ii) an undertaking letter prepared by the company that will be the new license holder, stating that all modifications and updates mandated for the product by the Ministry of Health will be made after the transfer.

If all documentation and information in the license transfer application made before the notary public is complete, the Ministry of Health will finalize the application within 30 days, in contrast to the 60-day period for this process in the previous version of the Regulation. It is noteworthy that another amendment of Article 25 of the Regulation provides for the license applicant's transfer of his/her rights arising out of that application to another natural person or legal entity fulfilling the requirements set out in Article 25 of the Regulation.

Finally, Article 26 of the Regulation pertaining to sales authorization has been abrogated. Prior to this abrogation, obtaining sales authorization was required before a licensed product could be marketed, in compliance with this Article. 

As license applications for medicinal products are crucial, the amendments introduced by the Regulation will undoubtedly affect practice in this area. However, in view of the nature of these amendments, we expect a smoother, clearer license application process.


1. Published in the Official Gazette dated 19 January 2005 and numbered 25705.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.